Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France

Value Health. 2014 Nov;17(7):A348. doi: 10.1016/j.jval.2014.08.715. Epub 2014 Oct 26.

Authors

S Roze¹, V Payet², F Debroucker², Portu S de³, M Cucherat⁴

Affiliations

¹ HEVA HEOR, Lyon, France.
² Medtronic France SAS, Boulogne-Billancourt, France.
³ Medtronic International Sàrl, Tolochenaz, Switzerland.
⁴ UMR CNRS 5558, Faculté de Médecine Laennec, Lyon, France.

PMID: 27200665
DOI: 10.1016/j.jval.2014.08.715

No abstract available